Spire Healthcare Group/£SPI
08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX
About Spire Healthcare Group
Spire Healthcare Group PLC, listed under the ticker SPI, is a prominent provider of private healthcare in the United Kingdom. The company operates a network of private hospitals and clinics offering comprehensive treatment options spanning various medical fields. Founded in 2007, Spire Healthcare has established a reputation for clinical excellence and responsive patient care.
Ticker
£SPI
Sector
Primary listing
LSE
Employees
15,703
Headquarters
Website
SPI Metrics
BasicAdvanced
£974M
52.26
£0.05
0.65
£0.02
0.96%
Price and volume
Market cap
£974M
Beta
0.65
52-week high
£2.57
52-week low
£1.68
Average daily volume
1.9M
Dividend rate
£0.02
Financial strength
Current ratio
0.641
Quick ratio
0.427
Long term debt to equity
160.898
Total debt to equity
175.918
Dividend payout ratio (TTM)
49.73%
Interest coverage (TTM)
1.44%
Profitability
EBITDA (TTM)
215.4
Gross margin (TTM)
45.21%
Net profit margin (TTM)
1.20%
Operating margin (TTM)
9.45%
Effective tax rate (TTM)
28.41%
Revenue per employee (TTM)
£100,000
Management effectiveness
Return on assets (TTM)
3.91%
Return on equity (TTM)
2.56%
Valuation
Price to earnings (TTM)
52.255
Price to revenue (TTM)
0.626
Price to book
1.32
Price to tangible book (TTM)
3.27
Price to free cash flow (TTM)
7.351
Free cash flow yield (TTM)
13.60%
Free cash flow per share (TTM)
0.327
Dividend yield (TTM)
0.96%
Growth
Revenue change (TTM)
6.95%
Earnings per share change (TTM)
-32.28%
3-year revenue growth (CAGR)
10.48%
10-year revenue growth (CAGR)
5.69%
3-year earnings per share growth (CAGR)
40.19%
10-year earnings per share growth (CAGR)
-8.64%
10-year dividend per share growth (CAGR)
-2.94%
What the Analysts think about SPI
Analyst ratings (Buy, Hold, Sell) for Spire Healthcare Group stock.
Bulls say / Bears say
Revenue grew 12.7% to £762.5 million in H1 2024 and adjusted EBITDA rose 10.8% to £130.6 million, driven by 9.7% growth in private medical insurance revenue and 5.2% growth in NHS revenue, reflecting robust demand across payer segments (FT).
New Services delivered a step-change with revenue rising to £59.7 million from £6.7 million and adjusted EBITDA moving to a £4.3 million profit from a £0.6 million loss, demonstrating successful diversification beyond hospitals (FT).
Spire has engaged Rothschild to explore a potential sale valuing the business at over £1.4 billion, signalling strong investor confidence in underlying asset quality and the potential for significant shareholder value realization (FT).
Net bank debt rose 30.1% year-on-year to £323.4 million as of June 30, 2024, with a net debt/EBITDA covenant ratio steady at 2.1×, potentially limiting financial flexibility for further investments (FT).
Adjusted free cash flow declined 22.5% to £18.6 million in H1 2024 despite rising profits, indicating cash conversion challenges that may pressure liquidity (FT).
Hospital admissions were flat year-on-year at 140,657 on a comparable basis, suggesting Spire is reliant on pricing gains rather than expanding patient volumes in its core business (FT).
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2025.
SPI Financial Performance
Revenues and expenses
SPI Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Spire Healthcare Group stock?
Spire Healthcare Group (SPI) has a market cap of £974M as of October 27, 2025.
What is the P/E ratio for Spire Healthcare Group stock?
The price to earnings (P/E) ratio for Spire Healthcare Group (SPI) stock is 52.26 as of October 27, 2025.
Does Spire Healthcare Group stock pay dividends?
Yes, the Spire Healthcare Group (SPI) stock pays dividends to shareholders. As of October 27, 2025, the dividend rate is £0.023 and the yield is 0.96%. Spire Healthcare Group has a payout ratio of 49.73% on a trailing twelve-month basis.
When is the next Spire Healthcare Group dividend payment date?
The next Spire Healthcare Group (SPI) dividend payment date is unconfirmed.
What is the beta indicator for Spire Healthcare Group?
Spire Healthcare Group (SPI) has a beta rating of 0.65. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.